Search clinical trials for: Avonex®

Total 14735 results

German University in Cairo

Recruiting

Drug Repurposing Using Metformin for Improving the Therapeutic Outcome in Multiple Sclerosis Patients

Multiple Sclerosis

Egypt
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Terminated

Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS)

Relapsing-remitting Multiple Sclerosis

United States, Germany
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Terminated

Study of Evobrutinib in Participants With RMS

Relapsing-remitting Multiple Sclerosis

United States, Germany
SC Medica

Not yet recruiting

Effectiveness and Safety of the Facet Fixation (FFX®) Implant in the Treatment of Degenerative Lumbar Spinal Stenosis (FFX® RCT)

Degenerative Lumbar Spinal Stenosis
Seattle Children's Hospital

Completed

Acupuncture to Improve Comfort of Children on a Ventilator in the Intensive Care Unit

Agitation

United States
Northumbria University
Naturex SA

Completed

To Assess the Influence of Aronox on Parameters Associated With Recovery Following Muscle Damaging Exercise

Muscle Damage

United Kingdom
Northumbria University
Naturex

Completed

To Assess the Influence of Aronox on Parameters Associated With Aerobic Performance

Aerobic Capacity

United Kingdom
Cairo University

Unknown

GBR With Ptfe With Bovine Bone With and Without Autogenous

Atrophied Anterior Maxillary Ridges

Egypt
EMD Serono
Merck Serono International SA

Completed

A Study of Rebif® Compared With Avonex® in the Treatment of Relapsing-remitting Multiple Sclerosis (MS)

Multiple Sclerosis, Relapsing-Remitting
Trio Medicines Ltd.
Biogen

Completed

Avonex®: Safety, Blood Levels and Effects (C-851)

Multiple Sclerosis (MS)

United Kingdom
Catrine Isehed
Umeå University

Completed

Regenerative Surgical Treatment of Peri-implantitis

Inflammation | Periodontal Diseases | Mouth Diseases | Bacterial Infections | Peri-implantitis | Infection | Failure of Dental Implant Due to Infection | Bleeding of Subgingival Space | Molecular Sequence Variation

Sweden
TherOx

Recruiting

A Prospective Real-World Multi-Center Post-Market Observational Evaluation of Supersaturated O2 Therapy Using the TherOx® Downstream® System (REAL)

Anterior Acute Myocardial Infarction (AMI)

United States
Organon and Co

Completed

Nasonex® Nasal Suspension 50 μg Long-term Designated Drug Use Investigation (Study P05876)

Allergic Rhinitis
Novartis Pharmaceuticals

Completed

Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change (EPOC)

Relapsing Remitting Multiple Sclerosis

Italy
Novartis Pharmaceuticals

Completed

A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis (EPOC)

Relapsing Forms of Multiple Sclerosis

United States, Canada, Puerto Rico
Windtree Therapeutics

Terminated

Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA

Respiratory Distress Syndrome

Canada, United States, Chile, Poland
Biogen

Completed

A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers

Multiple Sclerosis
University Health Network, Toronto
Merck Sharp & Dohme LLC; Canadian Institutes of Health Research (CIHR); Ontario... and other collaborators

Terminated

The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men (HPV-SAVE)

Anal Cancer | Human Papillomavirus | Anal Dysplasia

Canada
Neurognostics

Terminated

An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis

United States
Circassia Limited
Bioskin GmbH

Completed

Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Nekkar Lab Srl
Opera CRO, a TIGERMED Group Company

Recruiting

Study to Evaluate the Performance and Safety of the MARIAL® in Association With PPI Versus PPI Alone (GENYAL®)

Gastroesophageal Reflux Disease (GERD)

Italy, Romania
LEO Pharma
Tigermed Consulting Co., Ltd

Completed

Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population

Psoriasis Vulgaris

China
Colby Pharmaceutical Company

Completed

Safety, Tolerability and Immunogenicity of Fluzone® With and Without JVRS-100 in Elderly Subjects

Influenza
Fundació Sant Joan de Déu

Recruiting

Feasibility and Safety of Acupuncture in the Prevention of Late Irinotecan-related Diarrhea in Pediatric Patients (AIP2021)

Solid Tumor | Pediatric Cancer

Spain
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio...

Recruiting

PHOTOFINISH: a Clinical Study To Evaluate The Efficacy And Safety Of the System VULNOFAST® Plus/VULNOLIGHT® In Addition To The Usual Care (UC) Vs UC Alone For The Treatment Of Infected Diabetic Foot Ulcers (PHOTOFINISH)

Diabetic Foot Infection

Italy
Columbia University
Society of Family Planning

Completed

Acupuncture for Pain Management During Uterine Aspiration

Acupuncture | Pain Acute

United States
Arthrosi Therapeutics

Completed

Phase 2a Study of AR882 Alone and in Combination With Febuxostat or Allopurinol in Gout Patients

Gout Patients

New Zealand
Merck Sharp & Dohme LLC

Completed

Safety and Tolerability of Pembrolizumab (MK-3475) + Pegylated Interferon Alfa-2b and Pembrolizumab+ Ipilimumab in Participants With Advanced Melanoma or Renal Cell Carcinoma (MK-3475-029/KEYNOTE-29)

Melanoma | Renal Cell Carcinoma
Sanofi

Completed

Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide (TERIVA)

Multiple Sclerosis

Germany, Ukraine, Canada, Austria, Russian Federation
Teva Neuroscience, Inc.

Completed

Therapy Optimization in Multiple Sclerosis (MS) (TOP MS)

Multiple Sclerosis

United States
EMD Serono Research & Development Institute, Inc.

Completed

A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD) (ONWARD)

Multiple Sclerosis

United States, Italy, Russian Federation, Spain
Mylan Pharmaceuticals Inc

Completed

A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female Volunteers

Treatment of the Signs and Symptoms of Seasonal Allergic Rhinitis
State University of New York at Buffalo
Biogen

Completed

Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI Measures in Patients With MS

Multiple Sclerosis

United States
Bispebjerg Hospital
Malmö University

Completed

Safty and Feasibility Study of Therapeutic Cooling in Acute Ischemic Stroke (COOLAID Øresund)

Cerebral Infarction

Denmark
University Hospital Inselspital, Berne
Baxter Healthcare Corporation

Not yet recruiting

Sensory Recovery of Digital Nerves After Microsurgical Epineural Neurorrhaphy Alone or in Combination With Tisseel - RET (RET)

Digital Nerve Injuries

Switzerland
LEO Pharma

Completed

Efficacy and Safety of LEO 19123 Cream in the Treatment of Psoriasis Vulgaris

Psoriasis Vulgaris

Canada
University of Alberta

Withdrawn

Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth Syndrome

Burning Mouth Syndrome
Biogen

Completed

Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects

Multiple Sclerosis

United States
Biogen

Completed

Avonex-evaluation of Quality of Life and Convenience in Belgian Participants - The AVAIL Study (AVAIL)

Multiple Sclerosis

Belgium
Biogen

Completed

Open-Label Safety Extension Study of Avonex

Multiple Sclerosis
Biogen

Completed

Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers

Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®) (BRAVO)

Multiple Sclerosis

United States, Bulgaria, Croatia, Czechia, Estonia, Georgia, Germany, Israel, Italy, Lithuania, North Macedonia, Poland, Puerto Rico, Romania, Russian Federation, Slovakia, South Africa, Spain, Ukraine
Joseph Broderick
Medical University of South Carolina; National Institute of Neurological Disorders... and other collaborators

Terminated

Interventional Management of Stroke (IMS) III Trial (IMSIII)

Stroke

Canada, United States, Switzerland, Germany, Spain, Netherlands, Australia, France
Teva Branded Pharmaceutical Products R&D, Inc.

Withdrawn

A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ß-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) (LIBRETTO)

Relapsing Remitting Multiple Sclerosis
PD Dr. Marcus Müller
BfARM, Bonn; DZNE, Bonn

Unknown

Immune- and miRNA-response to Recombinant Interferon Beta in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RESI)

Relapsing-remitting Multiple Sclerosis

Germany
Biogen

Completed

A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis

Active Ulcerative Colitis

United States, Canada, Czech Republic, Hungary, Poland, Russian Federation, Slovakia
University of Calgary
McCaig Institute for Bone and Joint Health - Centre for Mobility and Joint...

Unknown

Evaluating the Effectiveness of Subchondroplasty for Treating Bone Marrow Lesions of the Knee

Knee Osteoarthritis | Osteoarthritis, Knee | Musculoskeletal Disease | Bone Marrow Edema | Arthroscopy | Subchondral Bone Edema

Canada
Biogen

Completed

Tolerability and Quality of Life Study in Participants Who Switched to Avonex Pen (SFERA)

Multiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Clinical Isolated Syndrome (CIS)

Czech Republic, Switzerland
Sanofi

Completed

Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis

Multiple Sclerosis

United States, Canada, Germany, Spain, Italy
Teva Pharmaceuticals USA

Completed

Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation

Seasonal Allergic Rhinitis

3

Subscribe